Pathogen reduction: State of reflection in Ireland

Transfusion Clinique et Biologique

Volumn 18, Issue 4, 2011, Pages 488-490

  Murphy, W G ^a  

^a National Blood Centre Ireland   (Ireland)

Author keywords

Bacteria; Blood transfusion; Complexity; Fresh frozen plasma; Health economics; Pathogen reduction; Platelets; VCJD

Indexed keywords

THROMBOCYTE CONCENTRATE;

ANALYTICAL PARAMETERS; ARTICLE; BACTERIUM CONTAMINATION; BLOOD DONOR; BLOOD RADIATION; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; COST BENEFIT ANALYSIS; CREUTZFELDT JAKOB DISEASE; CYTOMEGALOVIRUS; DISEASE TRANSMISSION; HEALTH CARE ORGANIZATION; HEALTH ECONOMICS; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; IRELAND; NONHUMAN; OUTCOME ASSESSMENT; PATHOGEN CLEARANCE; PATHOGEN REDUCTION TECHNOLOGY; PLASMA TRANSFUSION; PROCESS DESIGN; PROCESS OPTIMIZATION; PROCESS TECHNOLOGY; PUBLIC HEALTH; RESOURCE MANAGEMENT; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SHELF LIFE; SYSTEM ANALYSIS; THERAPY EFFECT; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; HUMANS; INFECTION CONTROL; IRELAND; PLATELET TRANSFUSION;

EID: 80051565057     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2011.05.004     Document Type: Article

References (11)

1. Murphy W. Managing threats rather than risk in blood transfusion: robust design for a complex system. Transfusion 2006, 46:2011-2013.
2. Murphy W.G., Foley M., Doherty C., Tierney G., Kinsella A., Salami A., et al. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008, 95:13-19.
3. Sharp P.M., Hahn B.H. The evolution of HIV-1 and the origin of AIDS. Philos Trans R Soc Lond B Biol Sci 2010, 365:2487-2494.
4. Brown P. On the origins of BSE. Lancet 1998, 352:252-253.
5. Campbell G.L., Marfin A.A., Lanciotti R.S., Gubler D.J. West Nile virus. Lancet Infect Dis 2002, 2:519-529.
6. Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology Am Soc Hematol Educ Program 2003:575-89. PMID 14633800.
7. Murphy W.G., Smyth J. Testing for bacteria in platelet concentrates: defining the parameters. Transfus Apheresis Sci 2001, 24:247-249.
8. Holden F., Foley M., Devin G., Kinsella A., Murphy W.G. Coagulase-negative staphylococcal contamination of whole blood and its components: the effects of WBC reduction. Transfusion 2000, 40:1508-1513.
9. Benjamin R.J., Wagner S.J. The residual risk of sepsis: modeling the effect of concentration on bacterial detection in two-bottle culture systems and an estimation of false-negative culture rates. Transfusion 2007, 47:1381-1389.
10. Magner J.J., Crowley K.J., Boylan J.F. Fatal fibrinolysis during orthotopic liver transplantation in patients receiving solvent/detergent-treated plasma (Octaplas). J Cardiothorac Vasc Anesth 2007 Jun, 21:410-413. Epub 2006 Dec 22.
11. Chekrizova V., Murphy W.G. Solvent-detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease, and in obstetric and gynaecological emergencies. Transfus Med 2006, 16:85-91.